Emily Abbott Among 13 Athletes to Fail Drug Test at Regionals

Emily Abbott at the 2018 CrossFit Games West Regional. Photo courtesy of CrossFit Inc.
Emily Abbott at the 2018 CrossFit Games West Regional. Photo courtesy of CrossFit Inc.

13. That is the number of athletes who have failed an in-competition drug test conducted at the regional competitions this year. Among those five that had qualified to compete at the 2018 CrossFit Games.

Emily Abbott was among those who tested positive for PEDs. Abbott, who finished 1st at the Regional and was set to compete at her 5th consecutive CrossFit Games, tested positive for ibutamoren, an anabolic agent. Because of this, Abbott has received a 4-year sanction that runs through June 2022.

Andrey Ganin was the other individual athlete who tested positive. According to Annie Thorisdottir, her boyfriend Frederik Aegidius has been invitied to compete in his place. Aegidius finished 6th at the Europe Regional.

There were three other team athletes who failed their tests as well. Laura Hosier was on Team East Woodbridge. That team finished 3rd at the East Regional. Hosier had admitted that she had failed her test almost a month ago. Team CrossFit Queens has apparently been invited to compete at the Games in their place.

The other two team athletes who tested positive were Dean Shaw (Meridian Regional – CrossFit Valley Road) and Maria Ceballos (Team Colombia Parceros). It is unclear if CrossFit will invite the next team in line.

Here is the complete list of athletes who have failed a drug test this year. The athletes in red had qualified for the CrossFit Games.

RANK FIRST NAME LAST NAME REG / DIV BANNED SUBSTANCE RESULT
1 Emily Abbott West / Indv. ibutamoren – anabolic agent 4-year sanction, ending June 2022
2 Dean Shaw Meridian / Team clomiphene – selective estrogen receptor modulator 4-year sanction, ending June 2022
3 Laura Hosier East / Team higenamine – beta-2 agonist 4-year sanction, ending June 2022
1 Maria Ceballos LatAm / Team stanozolol metabolites – anabolic agents 4-year sanction, ending June 2022
4 Andrey Ganin Europe / Indv. exogenous testosterone – anabolic agent 4-year sanction, ending June 2022
34 Nuha Almarri Meridian / Indv. GW1516 sulfoxide and GW1516 sulfone, metabolites of GW1516 and oral turinabol – metabolic modulator and anabolic androgenic steroid 4-year sanction, ending June 2022
5 Stephanie Araujo LatAm / Team stanozolol metabolite – anabolic agents 4-year sanction, ending June 2022
28 Joel Munro Pacific / Indv. metabolites of GW1516 – metabolic modulator 4-year sanction, ending June 2022
34 Rachel Campbell South / Indv. metabolite of oxandrolone – anabolic agent 4-year sanction, ending June 2022
37 Kara Paslay Central / Indv. 1,3-dimethylbutylamine – stimulant 2-year sanction, ending June 2020
28 Megan Benzik South / Indv. epimentendiol, metabolites of methandienone and oxandrolone, epioxandrolone, methanol, a letrozole metabolie, and amphetamine 4-year sanction, ending June 2022
25 Carlos Castillo LatAm / Team LGD4033 4-year sanction, ending June 2022
8 Gena Malkovskiy Europe / Indv. clomiphene, meldonium, and a metabolite of drostanolone 4-year sanction, ending June 2022